Paysign (NASDAQ:PAYS) Sets New 52-Week High – Here’s Why

Shares of Paysign, Inc. (NASDAQ:PAYS) hit a new 52-week high on Tuesday. The stock traded as high as $15.95 and last traded at $15.8650, with a volume of 236,577 shares trading hands. The stock had previously closed at $15.34.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the stock. Barrington Research set a $15.00 price objective on shares of Paysign in a research report on Tuesday, August 11th. DA Davidson lifted their price objective on shares of Paysign from $12.00 to $15.00 and gave the stock a “buy” rating in a research report on Wednesday, September 30th. Lake Street Capital increased their price objective on Paysign from $13.00 to $15.00 and gave the stock a “buy” rating in a report on Tuesday, September 15th. Wall Street Zen cut Paysign from a “strong-buy” rating to a “buy” rating in a research report on Sunday, August 16th. Finally, Weiss Ratings upgraded shares of Paysign from a “buy (b-)” rating to a “buy (b)” rating in a research report on Thursday, October 8th. Three investment analysts have rated the stock with a Buy rating. According to MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $15.00.

Paysign Stock Up 4.3%

The firm has a market cap of $903.59 million, a price-to-earnings ratio of 61.44 and a beta of 0.83. The stock has a 50 day moving average of $13.51 and a 200 day moving average of $9.57.

Paysign (NASDAQ:PAYS) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $0.11 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.05. Paysign had a return on equity of 30.13% and a net margin of 15.67%. The firm had revenue of $28.25 million during the quarter, compared to analyst estimates of $26.36 million. Paysign has set its FY 2026 guidance at 0.350-0.370 EPS and its Q3 2026 guidance at 0.090-0.100 EPS. As a group, analysts predict that Paysign, Inc. will post 0.58 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, CFO Jeffery Baker sold 35,000 shares of the business’s stock in a transaction dated Wednesday, August 12th. The stock was sold at an average price of $12.62, for a total transaction of $441,700.00. Following the completion of the transaction, the chief financial officer directly owned 542,171 shares in the company, valued at $6,842,198.02. The trade was a 6.06% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Mark Newcomer sold 50,000 shares of the company’s stock in a transaction that occurred on Friday, October 9th. The stock was sold at an average price of $15.34, for a total transaction of $767,000.00. Following the completion of the transaction, the chief executive officer owned 9,113,002 shares in the company, valued at approximately $139,793,450.68. This trade represents a 0.55% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 494,904 shares of company stock worth $6,095,124 over the last three months. Corporate insiders own 24.50% of the company’s stock.

Hedge Funds Weigh In On Paysign

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Legal & General Group Plc bought a new position in Paysign during the second quarter valued at approximately $35,000. EFG International AG bought a new stake in Paysign during the second quarter valued at approximately $68,000. Caitong International Asset Management Co. Ltd boosted its stake in shares of Paysign by 381.5% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 9,876 shares of the company’s stock worth $51,000 after acquiring an additional 7,825 shares during the last quarter. Quantbot Technologies LP purchased a new stake in shares of Paysign in the 2nd quarter worth $97,000. Finally, The Manufacturers Life Insurance Company bought a new stake in Paysign during the second quarter valued at about $100,000. 25.89% of the stock is owned by institutional investors.

About Paysign

Paysign, Inc (NASDAQ: PAYS) provides prepaid payment and financial technology solutions, with a focus on healthcare, pharmaceutical and other specialized markets. Its platform supports the issuance and management of prepaid cards, digital payments, account services and related payment-processing activities.

The company’s healthcare offerings include patient assistance and copay programs that help pharmaceutical manufacturers distribute financial support to eligible patients. Paysign also provides payment and card solutions for plasma collection centers, including programs used to compensate plasma donors.